Terms: = Lung cancer AND TERT, EST2, Q8NG46, Q8N6C3, Q2XS35, O14783, O14746, 7015, hEST2, TCS1, TRT, TP2 AND Treatment
235 results:
1. Comprehensive genomic profiling of pulmonary spindle cell carcinoma using tissue and plasma samples: insights from a real-world cohort analysis.
Sun Y; Qin S; Wang S; Pang J; Ou Q; Liang W; Zhong H
J Pathol Clin Res; 2024 May; 10(3):e12375. PubMed ID: 38661052
[TBL] [Abstract] [Full Text] [Related]
2. Six versus four or five cycles of first-line etoposide and platinum-based chemotherapy combined with thoracic radiotherapy in patients with limited-stage small-cell lung cancer: A propensity score-matched analysis of a prospective randomized trial.
Yu TT; Hu X; Liufu WJ; Niu SQ; Lian HM; Ma HL; Wang J; Bao Y; Chen M; Peng F
Cancer Med; 2024 Apr; 13(8):e7215. PubMed ID: 38659392
[TBL] [Abstract] [Full Text] [Related]
3. Efficacy and safety of thoracic radiotherapy in extensive-stage small-cell lung cancer patients receiving first-line immunotherapy plus chemotherapy: a propensity score matched multicentre retrospective analysis.
Yao Y; Li B; Song R; Yang L; Zou B; Wang L
Radiat Oncol; 2024 Feb; 19(1):25. PubMed ID: 38413988
[TBL] [Abstract] [Full Text] [Related]
4. Consolidative thoracic radiation therapy for extensive-stage small cell lung cancer in the era of first-line chemoimmunotherapy: preclinical data and a retrospective study in Southern Italy.
Longo V; Della Corte CM; Russo A; Spinnato F; Ambrosio F; Ronga R; Marchese A; Del Giudice T; Sergi C; Casaluce F; Gilli M; Montrone M; Gristina V; Sforza V; Reale ML; Di Liello R; Servetto A; Lipari H; Longhitano C; Vizzini L; Manzo A; Cristofano A; Paolelli L; Nardone A; De Summa S; Perrone A; Bisceglia C; Derosa C; Nardone V; Viscardi G; Galetta D; Vitiello F
Front Immunol; 2023; 14():1289434. PubMed ID: 38304255
[TBL] [Abstract] [Full Text] [Related]
5. Targeting interleukin-17 in radiation-induced toxicity and cancer progression.
Baindara P
Cytokine Growth Factor Rev; 2024 Feb; 75():31-39. PubMed ID: 38242827
[TBL] [Abstract] [Full Text] [Related]
6. Dosimetric predictors of radiation pneumonitis in patients with prior immunotherapy exposure: A multi-institutional analysis.
Bi J; Meng R; Yang D; Li Y; Cai J; Zhang L; Qian J; Xue X; Hu S; Yuan Z; Verma V; Bi N; Han G
Radiother Oncol; 2024 Jan; 190():110040. PubMed ID: 38042497
[TBL] [Abstract] [Full Text] [Related]
7. The Impact of Prophylactic Cranial Irradiation and Consolidative Thoracic Radiation Therapy for Extensive Stage Small-Cell lung cancer in the Transition to the Chemo-Immunotherapy Era: A Single Institution Series.
Gross AJ; Sheikh S; Kharouta M; Chaung K; Choi S; Margevicius S; Fu P; Machtay M; Bruno DS; Dowlati A; Biswas T
Clin Lung Cancer; 2023 Dec; 24(8):696-705. PubMed ID: 37993218
[TBL] [Abstract] [Full Text] [Related]
8. Intrathoracic Progression Is Still the Most Dominant Failure Pattern after First-Line Chemo-immunotherapy in Extensive-Stage Small-Cell lung cancer: Implications for Thoracic Radiotherapy.
Kim D; Kim HJ; Wu HG; Lee JH; Kim S; Kim TM; Kim JS; Kim BH
Cancer Res Treat; 2024 Apr; 56(2):430-441. PubMed ID: 37933113
[TBL] [Abstract] [Full Text] [Related]
9. Cerebrospinal fluid circulating tumour DNA genotyping and survival analysis in lung adenocarcinoma with leptomeningeal metastases.
Bai K; Chen X; Qi X; Zhang Y; Zou Y; Li J; Yu L; Li Y; Jiang J; Yang Y; Liu Y; Feng S; Bu H
J Neurooncol; 2023 Oct; 165(1):149-160. PubMed ID: 37897649
[TBL] [Abstract] [Full Text] [Related]
10. Efficacy and safety of thoracic radiotherapy for extensive stage small cell lung cancer after immunotherapy in real world.
Fang M; Wang L; Gu Q; Wu H; Du X; Lai X
Clin Exp Metastasis; 2023 Oct; 40(5):423-429. PubMed ID: 37584783
[TBL] [Abstract] [Full Text] [Related]
11. Evaluation of the interest to combine a CD4 Th1-inducer cancer vaccine derived from telomerase and atezolizumab plus bevacizumab in unresectable hepatocellular carcinoma: a randomized non-comparative phase II study (tertIO - PRODIGE 82).
Vienot A; Jacquin M; Rebucci-Peixoto M; Pureur D; Ghiringhelli F; Assenat E; Hammel P; Rosmorduc O; Stouvenot M; Allaire M; Bouattour M; Regnault H; Fratte S; Raymond E; Soularue E; Husson-Wetzel S; Di Martino V; Muller A; Clairet AL; Fagnoni-Legat C; Adotevi O; Meurisse A; Vernerey D; Borg C
BMC Cancer; 2023 Jul; 23(1):710. PubMed ID: 37516867
[TBL] [Abstract] [Full Text] [Related]
12. Real-world outcomes of PD-L1 inhibitors combined with thoracic radiotherapy in the first-line treatment of extensive stage small cell lung cancer.
Peng J; Zhang L; Wang L; Feng H; Yao D; Meng R; Liu X; Li X; Liu N; Tan B; Huang Z; Li S; Meng X
Radiat Oncol; 2023 Jul; 18(1):111. PubMed ID: 37403111
[TBL] [Abstract] [Full Text] [Related]
13. Genomic profile of Pancoast syndrome due to hepatocellular carcinoma: A case report.
Bergman DT; Zaki L; Pettus JR; Zaki BI; Amin M
Thorac Cancer; 2023 Jun; 14(18):1789-1792. PubMed ID: 37160416
[TBL] [Abstract] [Full Text] [Related]
14. Telomerase deficiency and dysfunctional telomeres in the lung tumor microenvironment impair tumor progression in NSCLC mouse models and patient-derived xenografts.
Piñeiro-Hermida S; Bosso G; Sánchez-Vázquez R; Martínez P; Blasco MA
Cell Death Differ; 2023 Jun; 30(6):1585-1600. PubMed ID: 37085672
[TBL] [Abstract] [Full Text] [Related]
15. Genomic and transcriptomic analysis of checkpoint blockade response in advanced non-small cell lung cancer.
Ravi A; Hellmann MD; Arniella MB; Holton M; Freeman SS; Naranbhai V; Stewart C; Leshchiner I; Kim J; Akiyama Y; Griffin AT; Vokes NI; Sakhi M; Kamesan V; Rizvi H; Ricciuti B; Forde PM; Anagnostou V; Riess JW; Gibbons DL; Pennell NA; Velcheti V; Digumarthy SR; Mino-Kenudson M; Califano A; Heymach JV; Herbst RS; Brahmer JR; Schalper KA; Velculescu VE; Henick BS; Rizvi N; Jänne PA; Awad MM; Chow A; Greenbaum BD; Luksza M; Shaw AT; Wolchok J; Hacohen N; Getz G; Gainor JF
Nat Genet; 2023 May; 55(5):807-819. PubMed ID: 37024582
[TBL] [Abstract] [Full Text] [Related]
16. Survival benefit of prophylactic cranial irradiation in limited-stage small-cell lung cancer in modern magnetic resonance imaging staging: a systematic review and meta-analysis.
Liu J; Shen B; Yang Y; Guo J; Ren W; Zhou Q; Mao J; Ye W; Wu D
Acta Oncol; 2023 Mar; 62(3):305-314. PubMed ID: 37010509
[TBL] [Abstract] [Full Text] [Related]
17. Use of radiation therapy among patients with Extensive-stage Small-cell lung cancer receiving Immunotherapy: Canadian consensus recommendations.
Sun A; Abdulkarim B; Blais N; Greenland J; Louie AV; Melosky B; Schellenberg D; Snow S; Liu G
Lung Cancer; 2023 May; 179():107166. PubMed ID: 36944282
[TBL] [Abstract] [Full Text] [Related]
18. Epigenetic and genetic inactivation of tumor suppressor miR-135a in non-small-cell lung cancer.
Choi JE; Jeon HS; Wee HJ; Lee JY; Lee WK; Lee SY; Yoo SS; Choi SH; Kim DS; Park JY
Thorac Cancer; 2023 Apr; 14(11):1012-1020. PubMed ID: 36869643
[TBL] [Abstract] [Full Text] [Related]
19. The effects of epirubicin-loaded Boc-L-Diphenylalanine peptide nanoparticles on cytotoxicity, genotoxicity, oxidative stress, and apoptosis in non-small cell lung cancer cells.
Altuntas S
Food Chem Toxicol; 2023 May; 175():113690. PubMed ID: 36842751
[TBL] [Abstract] [Full Text] [Related]
20. Thoracic Radiation in Limited Stage Small Cell lung cancer: Trends in Radiation Fractionation.
Kazemi M; Ladbury C; Liu J; Glaser S; Williams T; Amini A
Clin Lung Cancer; 2023 Jun; 24(4):322-328. PubMed ID: 36828750
[TBL] [Abstract] [Full Text] [Related]
[Next]
